Connect your AI

ADMA Biologics ADMA Intangible Amortization

Intangible Amortization at other companies

AbCellera Biologics Inc.ABCL

$920K-0.2%

ZymeworksZYME

$176K-89.1%

Adaptive BiotechnologiesADPT

$419K0.0%

DanaherDHR

$434M+5.9%

Other financials

Income statement

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ADMA Biologics's intangible amortization?: ADMA Biologics (ADMA) reported intangible amortization of $55K in Q1 2026.
How has ADMA Biologics's intangible amortization changed year-over-year?: ADMA Biologics's intangible amortization increased by 120.0% year-over-year, from $25K to $55K.
What is the long-term trend for ADMA Biologics's intangible amortization?: Over 2 years (2023 to 2025), ADMA Biologics's intangible amortization has grown at a -55.1% compound annual growth rate (CAGR), from $724K to $146K.
What does intangible amortization mean?: Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.